Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CYTX

Cytori Therapeutics

$0.36

0.003 (0.83%)

16:17
09/01/17
09/01
16:17
09/01/17
16:17
Hot Stocks
Cytori announces corporate restructuring, cost reduction plan »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$10.70

0.05 (0.47%)

, ATHX

Athersys

10:56
08/28/17
08/28
10:56
08/28/17
10:56
Hot Stocks
FDA statement on new oversight policy for stem cell and regenerative medicine »

The following is an…

SGMO

Sangamo

$10.70

0.05 (0.47%)

ATHX

Athersys

CBMG

Cellular Biomedicine

CYTX

Cytori Therapeutics

$0.36

0.0282 (8.50%)

KOOL

Cesca Therapeutics

$3.35

0.15 (4.69%)

VTGN

VistaGen Therapeutics

$1.75

-0.02 (-1.13%)

PSTI

Pluristem

$1.14

0.02 (1.79%)

BCLI

BrainStorm

$4.18

-0.03 (-0.71%)

CLBS

Caladrius

$4.24

0.12 (2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

CYTX

Cytori Therapeutics

$0.37

0.0311 (9.28%)

17:19
08/14/17
08/14
17:19
08/14/17
17:19
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.35

0.0098 (2.88%)

08:22
08/11/17
08/11
08:22
08/11/17
08:22
Recommendations
Cytori Therapeutics analyst commentary at Maxim »

Cytori may still have a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.35

0.0098 (2.88%)

16:53
08/10/17
08/10
16:53
08/10/17
16:53
Earnings
Cytori Therapeutics reports Q EPS (19c), consensus (21c) »

Q2 2017 and year-to-date…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

UA

Under Armour

$18.21

-0.0485 (-0.27%)

, UAA

Under Armour

$20.29

0.02 (0.10%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

UA

Under Armour

$18.21

-0.0485 (-0.27%)

UAA

Under Armour

$20.29

0.02 (0.10%)

SNAP

Snap

$13.73

-0.355 (-2.52%)

CYTX

Cytori Therapeutics

$0.48

-0.6301 (-56.77%)

LULU

lululemon

$62.02

0.08 (0.13%)

POWI

Power Integrations

$81.75

0.2 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 10

    Aug

  • 13

    Sep

CYTX

Cytori Therapeutics

$0.48

-0.6301 (-56.77%)

05:22
07/25/17
07/25
05:22
07/25/17
05:22
Downgrade
Cytori Therapeutics rating change at B. Riley »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CYTX

Cytori Therapeutics

$1.11

-0.01 (-0.89%)

08:43
07/24/17
07/24
08:43
07/24/17
08:43
Conference/Events
Cytori Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$1.11

-0.01 (-0.89%)

08:30
07/24/17
07/24
08:30
07/24/17
08:30
Hot Stocks
Breaking Hot Stocks news story on Cytori Therapeutics »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$1.11

-0.01 (-0.89%)

08:16
07/24/17
07/24
08:16
07/24/17
08:16
Hot Stocks
Cytori Therapeutics announces tiop-line results from STAR trial of Habeo »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.